Omega Scan Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 04-10-2024
- Paid Up Capital ₹ 6.60 M
as on 04-10-2024
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.66 Cr
as on 04-10-2024
- Revenue 23.00%
(FY 2023)
- Profit 453.51%
(FY 2023)
- Ebitda 232.69%
(FY 2023)
- Net Worth 52.65%
(FY 2023)
- Total Assets -11.82%
(FY 2023)
About Omega Scan Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.60 M.
The company currently has active open charges totaling ₹14.66 Cr.
Abhimanyu Kelkar, Mukul Mutatkar, Arun Roy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85101MH1997PTC112370
- Company No.
112370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Omega Scan Diagnostics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukul Mutatkar  | Whole-Time Director | 16-Dec-1997 | Current |
| Abhimanyu Kelkar | Whole-Time Director | 26-Feb-1998 | Current |
| Arun Roy | Whole-Time Director | 26-Feb-1998 | Current |
| Avinash Kelkar | Whole-Time Director | 16-Dec-1997 | Current |
| Gajanan Mudliar | Whole-Time Director | 26-Feb-1998 | Current |
Financial Performance of Omega Scan Diagnostics.
Omega Scan Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23% increase. The company also saw a substantial improvement in profitability, with a 453.51% increase in profit. The company's net worth Soared by an impressive increase of 52.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omega Scan Diagnostics?
In 2023, Omega Scan Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Poona Diagnostic Services Private LimitedActive 26 years 5 monthsAbhimanyu Kelkar, Mukul Mutatkar and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Dec 2016 | ₹9.52 Cr | Open |
Icici Bank Limited Creation Date: 22 Mar 2007 | ₹1.16 Cr | Open |
Icici Bank Ltd Creation Date: 27 Feb 2003 | ₹3.98 Cr | Open |
How Many Employees Work at Omega Scan Diagnostics?
Unlock and access historical data on people associated with Omega Scan Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omega Scan Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omega Scan Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
